您的位置: 首页 > 农业专利 > 详情页

CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR USE IN CELL THERAPY AGAINST CANCER AND INFECTIOUS DISEASE
专利权人:
ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.;NATIONAL UNIVERSITY OF SINGAPORE
发明人:
Dario Campana,Yu-Hsiang Chang
申请号:
US15337854
公开号:
US20170107491A1
申请日:
2016.10.28
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The invention provides a chimeric receptor comprising NKG2D, DAP10 and CD3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of NK cells. The invention also encompansses methods for use of NKG2D-DAP10-CD3 zeta polypeptides, vectors and cells in methods for treating cancer and other proliferative disorders, as well as infectious diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充